Clinical significance of the expression of EGFR signaling pathway-related proteins in esophageal squamous cell carcinoma

Tumor Biology

Volumn 35, Issue 1, 2014, Pages 651-657

  Li, Jian Cheng ^a   Zhao, Yun Hui ^b   Wang, Xiao Ying ^a   Yang, Yan ^a   Pan, Ding Long ^a   Qiu, Zi Dan ^a   Su, Ying ^a   Pan, Jian Ji ^a  

^a FUJIAN PROVINCIAL TUMOR HOSPITAL   (China)

^b Putian College Hospital   (China)

Author keywords

C erb B2; C Fos; EGFR; Esophageal squamous cell carcinoma

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; PROTEIN C FOS;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; DISTANT METASTASIS; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGOSCOPE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TUMOR GROWTH; TUMOR INVASION; VERY ELDERLY;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; FEMALE; GENE EXPRESSION; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; PROTO-ONCOGENE PROTEINS C-FOS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; SIGNAL TRANSDUCTION;

EID: 84894481137     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-013-1089-0     Document Type: Article

References (20)

1. Pennathur A, Gibson MK, Jobe BA, et al. Oesophageal cancer. Lancet. 2013;381:400-12.
2. Villaflor VM, Allaix ME, Minsky B, et al. Multidisciplinary approach for patients with esophageal cancer. World J Gastroenterol. 2012;18:6737-46.
3. Capdevila J, Elez E, Macarulla T, et al. Anti-epidermal growth factor receptor monoclonal antibodies in cancer treatment. Cancer Treat Rev. 2009;35:354-63.
4. Hong TS,Wo JY, Kwak EL. Targeted therapies with chemoradiation in esophageal cancer: development and future directions. Semin Radiat Oncol. 2013;23:31-7.
5. Abedi-Ardekani B, Dar NA,MirMM, et al. Epidermal growth factor receptor (EGFR) mutations and expression in squamous cell carcinoma of the esophagus in central Asia. Bmc Cancer. 2012;12:602.
6. Woodburn JR. The epidermal growth factor receptor and its inhibition in cancer therapy. Pharmacol Ther. 1999;82:241-50.
7. Kono K, Mimura K, Fujii H, et al. Potential therapeutic significance of HER-family in esophageal squamous cell carcinoma. Ann Thorac Cardiovasc Surg. 2012;18:506-13.
8. Wilkinson NW, Black JD, Roukhadze E, et al. Epidermal growth factor receptor expression correlates with histologic grade in resected esophageal adenocarcinoma. J Gastrointest Surg. 2004;8:448-53.
9. Langer R, Von Rahden BH, Nahrig J, et al. Prognostic significance of expression patterns of c-erbB-2, p53, p16INK4A, p27KIP1, cyclin D1 and epidermal growth factor receptor in oesophageal adenocarcinoma: a tissue microarray study. J Clin Pathol. 2006;59:631-4.
10. Wei Q, Chen L, Sheng L, et al. EGFR, HER2 and HER3 expression in esophageal primary tumours and corresponding metastases. Int J Oncol. 2007;31:493-9.
11. Miyawaki M, Hijiya N, Tsukamoto Y, et al. Enhanced phosphorylation of the epidermal growth factor receptor at the site of tyrosine 992 in esophageal carcinomas. APMIS. 2008;116:1097-106.
12. van Straaten F, Muller R, Curran T, et al. Complete nucleotide sequence of a human c-onc gene: deduced amino acid sequence of the human c-Fos protein. Proc Natl Acad Sci U S A. 1983;80:3183-7.
13. Liu H, Al-Aidaroos AQ,Wang H, et al. PRL-3 suppresses c-Fos and integrin alpha2 expression in ovarian cancer cells. Bmc Cancer. 2013;13:80.
14. Wu MY, Zhuang CX, Yang HX, et al. Expression of Egr-1, c-Fos and cyclin D1 in esophageal cancer and its precursors: an immunohistochemical and in situ hybridization study. World J Gastroenterol. 2004;10:476-80.
15. Mahner S, Baasch C, Schwarz J, et al. C-Fos expression is a molecular predictor of progression and survival in epithelial ovarian carcinoma. Br J Cancer. 2008;99:1269-75.
16. Slamon DJ, Clark GM, Wong SG, et al. Human breast cancer: correlation of 25 relapse and survival with amplification of the HER-2/neu oncogene. Science. 1987;235:177-82.
17. Yano T, Doi T, Ohtsu A, et al. Comparison of HER2 gene amplification assessed by fluorescence in situ hybridization and HER2 protein expression assessed by immunohistochemistry in gastric cancer. Oncol Rep. 2006;15:65-71.
18. Almhanna K, Meredith KL, Hoffe SE, et al. Targeting the human epidermal growth factor receptor 2 in esophageal cancer. Cancer Control. 2013;20:111-6.
19. Yoon HH, Shi Q, Sukov WR, et al. Adverse prognostic impact of intratumor heterogeneous HER2 gene amplification in patients with esophageal adenocarcinoma. J Clin Oncol. 2012;30:3932-8.
20. Cappetta A, Lonardi S, Pastorelli D, et al. Advanced gastric cancer (GC) and cancer of the gastro-oesophageal junction (GEJ): focus on targeted therapies. Crit Rev Oncol Hematol. 2012;81:38-48.